In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arachnova, Sosei partner on incontinence candidate

Executive Summary

Sosei (private Japanese drug reprofiler) has partnered with Arachnova Therapeutics Ltd. (employs therapeutic switching methodology to find new uses for existing late preclinical/early clinical drug candidates) on development of AA10020/SOU001 for stress urinary incontinence (SUI).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies